The PI3K, Metabolic, and Autophagy Networks: Interactive Partners in Cellular Health and Disease

被引:97
作者
Shanware, Naval P. [1 ]
Bray, Kevin [1 ]
Abraham, Robert T. [2 ]
机构
[1] Pfizer Worldwide Res & Dev, Oncol Res Unit, Pearl River, NY 10965 USA
[2] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA 92121 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 | 2013年 / 53卷
关键词
cancer; metabolism; autophagy; mTOR; lysosomes; PROTEIN-TYROSINE PHOSPHATASES; PHOSPHOINOSITIDE; 3-KINASE; MAMMALIAN TARGET; MTOR; CANCER; GLUTAMINE; GROWTH; P62; PHOSPHORYLATION; INHIBITORS;
D O I
10.1146/annurev-pharmtox-010611-134717
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A fundamental imperative for mammalian cells is to coordinate cell metabolism and growth with environmentally induced stress. This review focuses on three highly integrated networks-the phosphoinositide 3-kinase (PI3K) signaling cascade, intermediate metabolism, and autophagy-that work together to maintain cellular homeostasis under basal conditions and to drive cell-mass accumulation and cell cycle progression in the presence of appropriate mitogenic stimuli. Dysfunction within any one of these networks results in compensatory responses from the other networks. These responses underpin several pathologies associated with major human diseases such as cancer. We discuss the PI3K, metabolism, and autophagy networks and provide selected insights into internetwork cross-talk mechanisms. In recognition of the extensive interactions observed in both healthy and diseased cells, we propose that the three networks be merged into a "metabolism-signaling supernetwork." A detailed understanding of this supernetwork will facilitate the development of novel therapies for cancer and other complex diseases.
引用
收藏
页码:89 / 106
页数:18
相关论文
共 98 条
  • [1] 18F-FDG PET/CT Imaging In Oncology
    Almuhaideb, Ahmad
    Papathanasiou, Nikolaos
    Bomanji, Jamshed
    [J]. ANNALS OF SAUDI MEDICINE, 2011, 31 (01) : 3 - 13
  • [2] Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
    Amaravadi, Ravi K.
    Lippincott-Schwartz, Jennifer
    Yin, Xiao-Ming
    Weiss, William A.
    Takebe, Naoko
    Timmer, William
    DiPaola, Robert S.
    Lotze, Michael T.
    White, Eileen
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (04) : 654 - 666
  • [3] Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI 10.1089/ARS.2008.2270
  • [4] ATP citrate lyase is an important component of cell growth and transformation
    Bauer, DE
    Hatzivassiliou, G
    Zhao, FP
    Andreadis, C
    Thompson, CB
    [J]. ONCOGENE, 2005, 24 (41) : 6314 - 6322
  • [5] p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death
    Bjorkoy, G
    Lamark, T
    Brech, A
    Outzen, H
    Perander, M
    Overvatn, A
    Stenmark, H
    Johansen, T
    [J]. JOURNAL OF CELL BIOLOGY, 2005, 171 (04) : 603 - 614
  • [6] Regulation of cancer cell metabolism
    Cairns, Rob A.
    Harris, Isaac S.
    Mak, Tak W.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (02) : 85 - 95
  • [7] The phosphoinositide 3-kinase pathway
    Cantley, LC
    [J]. SCIENCE, 2002, 296 (5573) : 1655 - 1657
  • [8] The PTEN-PI3K pathway: of feedbacks and cross-talks
    Carracedo, A.
    Pandolfi, P. P.
    [J]. ONCOGENE, 2008, 27 (41) : 5527 - 5541
  • [9] Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079
  • [10] Sirtuins mediate mammalian metabolic responses to nutrient availability
    Chalkiadaki, Angeliki
    Guarente, Leonard
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (05) : 287 - 296